ClinicalTrials.gg
RecruitingNCT07932353Updated Nov 12, 2026

A Study on the Pain and Immune Characteristics of Lumbar Disc Herniation Treated With the Five-Step Manipulation Method

An interventional study of Five-step Manipulation and traditional Tuina in Pain, Lumbar Spine Function and Muscle Tone, sponsored by Lijiang Lv. Recruiting at 1 site in China. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Lijiang Lv · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Dec 2025, registered Nov 2026).
  • Started Dec 2025; still recruiting 10 months later.
Updated Nov 12, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 245 studies in Pain with a site in China — 65 open to participants now, 71 under way, 2 of them phase 3. Pain · China.

Planned enrollment
102nd of 210
120 · median 120
Started
2025
with 34 others
No phase
115 of 245
39 open now
Primary completion
2027-12
later than 60 of 70 live
Registered
245th of 245
by date

Among the 245 studies in Pain with a site in China, this one is the 102nd largest by planned enrollment of the 210 interventional ones that give a count, is one of 35 that started in 2025, is one of 115 with no phase, reaches primary completion later than 60 of the 70 other live ones, and was the 245th registered.

Pain

10,069 studies on the registry are indexed under Pain; 1,651 are open to participants now.

Browse Pain studies →

Open to participants now

65 of the 245 studies in Pain with a site in China are open now. Recruiting first, the newest first:

59 more — sign in →

All 65 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 928 Pain studies recruiting now, 383 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 245 studies in Pain with a site in China, or all of them as a file.
02

Study summary

To investigate the differences in the efficacy of Five-step Manipulation and traditional Tuina in improving pain, lumbar spine function, muscle tone, pain threshold, sciatic nerve conduction velocity, cutaneous heat values and serum immune markers in patients with lumbar disc herniation.

03

Conditions studied

  • Pain
  • Lumbar Spine Function
  • Muscle Tone
  • Surface Infrared Heat Value
  • Serum Immunological Markers

Browse trials for

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Meets the diagnostic criteria for lumbar disc herniation;
  2. Aged between 18 and 60 years;
  3. Pain intensity is moderate or severe (100 mm Visual Analogue Scale [VAS] score ≥ 40);
  4. The patient's lower back and leg pain is in the non-acute phase (symptoms have persisted for more than 2 weeks);
  5. Unilateral lumbar disc herniation has caused sciatica for more than 3 months;
  6. Has not taken analgesics, neurotrophic agents or sedatives within the last month, and has not undergone systematic treatment;
  7. Voluntarily participates in the clinical trial and has signed an form; 3. Has normal verbal expression and comprehension abilities, is able to communicate effectively and complete the relevant questionnaires.

Exclusion criteria

Exclusion Criteria:

  1. Patients with severe spinal or neurological disorders;
  2. Patients with severe concomitant heart, liver or kidney-related conditions;
  3. Patients with a history of lumbar disc surgery, or who have undergone invasive lumbar examinations within the past three months, or who have severe spinal cord injury, neurological dysfunction, or indications for surgery;
  4. Patients currently taking medication effective against sciatica and those planning to undergo surgery or interventional treatment;
  5. Patients with lumbar spondylolisthesis, lumbar tumours or tuberculosis;
  6. Women who are pregnant, planning to become pregnant or currently breastfeeding;
  7. Patients with mental health conditions or poor clinical compliance;
  8. Patients who have undergone traditional Chinese medical therapies such as spinal Tuina or acupuncture, or physiotherapy for lumbar disc herniation within the past three months.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Five-step Manipulation

    Other: Five-step Manipulation

  • Active comparator
    traditional Tuina

    Other: traditional Tuina

Interventions

  • OtherFive-step Manipulation

    TheFive-step Manipulation comprises lumbar mobilisation, lumbar traction, lever-assisted lumbar realignment, supine lumbar rotation and 'jin' realignment. Nine treatment sessions are carried out over a three-week period, at a frequency of three sessions per week, with each session lasting approximately 25 minutes.

  • Othertraditional Tuina

    Traditional Chinese Tuina stimulates acupoints and muscles, relaxing the lower back for 25 minutes

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale, VAS

    Time frame: From enrollment to the end of treatment at 3 weeks

Secondary outcomes

  1. Oswestry Disability Index, ODI

    Time frame: From enrollment to the end of treatment at 3 weeks

  2. Shift in the pain threshold

    Time frame: From enrollment to the end of treatment at 3 weeks

  3. Pressure pain threshold

    Time frame: From enrollment to the end of treatment at 3 weeks

  4. Difference in surface infrared temperature

    Time frame: From enrollment to the end of treatment at 3 weeks

  5. Differences in the expression of serum immune markers

    Time frame: From enrollment to the end of treatment at 3 weeks

07

Study locations

1 of 1 sites recruiting
  • The Third Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
    Hangzhou, Zhejiang 310053, China
    Recruiting
    • Zhen Liu · Contact+86-17764565717
08

References and documents

Publications

  • 腰椎间盘突出症诊疗中国疼痛专家共识[J].中国疼痛医学杂志,2020,26(1):2-6.
  • Nguyen C, Boutron I, Zegarra-Parodi R, Baron G, Alami S, Sanchez K, Daste C, Boisson M, Fabre L, Krief P, Krief G, Lefevre-Colau MM, Rannou F. Effect of Osteopathic Manipulative Treatment vs Sham Treatment on Activity Limitations in Patients With Nonspecific Subacute and Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Intern Med. 2021 May 1;181(5):620-630. doi: 10.1001/jamainternmed.2021.0005. PubMed 33720272 ↗
  • Tu JF, Shi GX, Yan SY, Ni GX, Yu FT, Cai GW, Liu ZS, Ma CY, Wang LQ, Yang JW, Zhou XQ, Meng XL, Fu HY, Li J, Wan WJ, Sun TH, Wang XZ, Liu CZ. Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk: A Randomized Clinical Trial. JAMA Intern Med. 2024 Dec 1;184(12):1417-1424. doi: 10.1001/jamainternmed.2024.5463. PubMed 39401008 ↗
  • Kreiner DS, Hwang SW, Easa JE, Resnick DK, Baisden JL, Bess S, Cho CH, DePalma MJ, Dougherty P 2nd, Fernand R, Ghiselli G, Hanna AS, Lamer T, Lisi AJ, Mazanec DJ, Meagher RJ, Nucci RC, Patel RD, Sembrano JN, Sharma AK, Summers JT, Taleghani CK, Tontz WL Jr, Toton JF; North American Spine Society. An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. Spine J. 2014 Jan;14(1):180-91. doi: 10.1016/j.spinee.2013.08.003. Epub 2013 Nov 14. PubMed 24239490 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Dec 2027, 23 months after the start.

Of 3,738 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 23 months is above that.

Counting every sponsor, half of 3,837 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2026
First posted
Nov 12, 2026
StartActual
Dec 30, 2025
Primary completionEst.
Dec 28, 2027
CompletionEst.
Jan 27, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07932353
Lead sponsor
Lijiang Lv
Responsible party
Lijiang Lv (professor, The Third Affiliated hospital of Zhejiang Chinese Medical University) — Sponsor-investigator
First posted
Nov 12, 2026
Start date
Dec 30, 2025
Primary completion
Dec 28, 2027 (estimated)
Completion
Jan 27, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Lijiang Lv
Contact
lvlijiang0288@163.com
+86-18958077865

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion